Vertex Pharmaceuticals Inc
BMV:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
R
|
Regions Financial Corp
F:RN7
|
US |
|
A
|
African Rainbow Minerals Ltd
XBER:EB9
|
ZA |
|
Avery Dennison Corp
NYSE:AVY
|
US |
Wall St Price Targets
VRTX Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VRTX is 9 789.171 MXN with a low forecast of 6 121.6034 MXN and a high forecast of 11 855.3033 MXN.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
9 789.171
MXN
According to Wall Street analysts, the average 1-year price target for VRTX is 9 789.171 MXN with a low forecast of 6 121.6034 MXN and a high forecast of 11 855.3033 MXN.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 8 years is 14%.
